Back to Dashboard
SUPN · Healthcare

Supernus Pharmaceuticals

USA Healthcare Filing: 2026-06-30
28/100
Smart-money confidence
Below average interest

1 member of Congress bought

Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →

7
hedge funds
hold it · 2 new, 2 added, 3 trimmed
1
in Congress
traded it in the past year · 1 bought, 0 sold
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works Consensus buy — 2 of 3 sources positive →
Market cap
$6.2B
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Exchange
NasdaqGS
About SUPERNUS PHARMACEUTICALS

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX…

Who's behind the signal
Every informed buyer we can see on SUPN, across all three feeds.
Hedge funds · 7
D.E. Shaw & Co Increased +23%
Renaissance Technologies Decreased −13%
Citadel Advisors Decreased −8%
+1 more in the full breakdown below ↓
Congress · 2
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 9 on record
Disclosures from 2020-05-28 to 2026-03-03
Trade date Member Chamber Action Amount
2026-03-03 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2025-12-11 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2025-10-09 Gilbert Ray Cisneros, Jr. · D-CA House Sold $1,001 - $15,000
2025-03-24 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2022-12-23 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2020-11-13 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2020-07-17 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2020-06-01 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2020-05-28 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
Not a model pick — but on our radar. SUPERNUS PHARMACEUTICALS isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
2
New positions
2
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset Pinch to zoom · drag sideways to move through time
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to SUPERNUS PHARMACEUTICALS
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell SUPERNUS PHARMACEUTICALS or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订 · 隐私